Results for deferiprone translation from English to Latvian

deferiprone
deferipron

ferriprox deferiprone
ferriprox deferiprons

the active substance is deferiprone.
aktīvā viela ir deferiprons.

one tablet contains 500 mg deferiprone
vienā tabletē ir 500 mg deferiprona

each tablet contains 500 mg deferiprone.
viena tablete satur 500 mg deferiprona.

ferriprox 100 mg/ ml oral solution deferiprone
ferriprox 100 mg/ ml iekšķīgi lietojams šķīdums deferiprone

each 1000 mg tablet contains 1000 mg deferiprone.
katra tablete satur 1000 mg deferiprona.

ferriprox 1000 mg film-coated tablets deferiprone
ferriprox 1000 mg apvalkotās tabletes deferiprone

each ml of oral solution contains 100 mg deferiprone.
katrs iekšķīgi lietojamā šķīduma ml satur 100 mg deferiprona.

deferiprone is metabolised predominantly to a glucuronide conjugate.
deferiprons pārsvarā tiek metabolizēts glikuronīda konjugātā.

deferiprone must not be used by breast-feeding mothers.
deferiponu nedrīkst lietot mātes, kuras baro bērnu ar krūti.

the neurological disorders progressively regressed after deferiprone discontinuation.
pēc deferiprona lietošanas pārtraukšanas neiroloģiskie traucējumi pakāpeniski samazinājās.

deferiprone has been shown to cause neutropenia, including agranulocytosis.
ir pierādīts, ka deferiprons izraisa neitropēniju, tai skaitā agranulocitozi.

the active substance in ferriprox, deferiprone, is an iron chelator.
ferriprox aktīvā viela deferiprons ir dzelzs helators.

important safety reminders for patients taking ferriprox (deferiprone)
((aizmugures vāks)) ((priekšējais vāks))

treatment with deferiprone should not be initiated if the patient is neutropenic.
Ārstēšanu ar deferipronu nedrīkst nozīmēt pacientiem ar neitropēniju.

in one study of two-year duration deferiprone was compared to deferoxamine.
vienā divu gadu ilgā pētījumā deferiprons tika salīdzināts ar deferoksamīnu.

low plasma zinc levels have been associated with deferiprone in a minority of patients.
ar deferipronu saistīts zems plazmas cinka līmenis tika novērots nelielai pacientu daļai.

increased levels of serum liver enzymes have been reported in patients taking deferiprone.
deferipronu lietojošiem pacientiem tika novērots paaugstināts aknu enzīmu līmenis serumā.

peak serum concentrations of the glucuronide occur 2 to 3 hours after administration of deferiprone.
augstākā glikuronīda koncentrācija serumā tiek sasniegta 2 līdz 3 stundu laikā pēc deferiprona iedzeršanas.